Skip to main content

Published locations for Secukinumab for psoriasis at 4 years: undiminished efficacy and safety

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Secukinumab for psoriasis at 4 years: undiminished efficacy and safety

User login

  • Reset your password
  • /content/secukinumab-psoriasis-4-years-undiminished-efficacy-and-safety
  • /edermatologynews/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished-efficacy-and
  • /familypracticenews/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished-efficacy-and
  • /internalmedicinenews/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished-efficacy
  • /rheumatologynews/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished-efficacy-and
  • /rheumatology/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished-efficacy-and-safety
  • /internalmedicine/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished-efficacy-and
  • /dermatology/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished-efficacy-and-safety
  • /familymedicine/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished-efficacy-and
  • /rheumatology/psoriatic-arthritis-resource-center/article/115936/psoriasis/secukinumab-psoriasis-4
  • /dermatology/psoriasiscollection/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished
  • /psoriatic-arthritis-icymi/article/115936/psoriasis/secukinumab-psoriasis-4-years-undiminished